20-45477098-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006103.4(WFDC2):c.224-2844C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.322 in 151,620 control chromosomes in the GnomAD database, including 9,327 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.32 ( 9327 hom., cov: 31)
Consequence
WFDC2
NM_006103.4 intron
NM_006103.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.838
Publications
2 publications found
Genes affected
WFDC2 (HGNC:15939): (WAP four-disulfide core domain 2) This gene encodes a protein that is a member of the WFDC domain family. The WFDC domain, or WAP Signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor in many family members. This gene is expressed in pulmonary epithelial cells, and was also found to be expressed in some ovarian cancers. The encoded protein is a small secretory protein, which may be involved in sperm maturation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.598 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| WFDC2 | NM_006103.4 | c.224-2844C>G | intron_variant | Intron 2 of 3 | ENST00000372676.8 | NP_006094.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| WFDC2 | ENST00000372676.8 | c.224-2844C>G | intron_variant | Intron 2 of 3 | 1 | NM_006103.4 | ENSP00000361761.3 |
Frequencies
GnomAD3 genomes AF: 0.322 AC: 48788AN: 151500Hom.: 9295 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
48788
AN:
151500
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.322 AC: 48870AN: 151620Hom.: 9327 Cov.: 31 AF XY: 0.329 AC XY: 24380AN XY: 74082 show subpopulations
GnomAD4 genome
AF:
AC:
48870
AN:
151620
Hom.:
Cov.:
31
AF XY:
AC XY:
24380
AN XY:
74082
show subpopulations
African (AFR)
AF:
AC:
20316
AN:
41286
American (AMR)
AF:
AC:
5470
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
AC:
816
AN:
3466
East Asian (EAS)
AF:
AC:
3153
AN:
5116
South Asian (SAS)
AF:
AC:
2016
AN:
4806
European-Finnish (FIN)
AF:
AC:
2620
AN:
10484
Middle Eastern (MID)
AF:
AC:
100
AN:
294
European-Non Finnish (NFE)
AF:
AC:
13595
AN:
67902
Other (OTH)
AF:
AC:
707
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1504
3007
4511
6014
7518
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
480
960
1440
1920
2400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1898
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.